Polaris

Polaris sells Hamlet Protein to Altor and Goldman Sachs

Polaris Private Equity has successfully sold its portfolio company Hamlet Protein to Altor Fund IV and Goldman Sachs Merchant Banking Division. Altor and Goldman Sachs have acquired a majority stake in Hamlet Protein from Polaris – which recently held a second close on its latest private equity fund and has commitments in excess of the target of €400m – and founder Ole. K. Hansen.

Hamlet Protein is a global provider of soy-based protein solutions used in high value-add animal feed for young animals. During Polaris’ investment the company has roughly tripled in size in terms of revenues and has expanded internationally including into the US. The company now services more than 50 countries from its two production facilities in Horsens, Denmark and Findlay, Ohio.

“We have made a successful management succession and turned Hamlet Protein into a leading global provider of specialty soya for young animal feed with a strong market position in Europe, US and Asia through developing global sales organization and significant investments in expanding capacity including establishing a sales and production facility in the US”, says Niels Worning, Partner at Polaris Private Equity.

N.B. – The text does not bind the staff of LMFInternational. Only the companies, organizations and associations which sign the press release and which are clearly indicated in the title of the text, are responsible for its information and contents.